Journal of Medicinal Chemistry · 2007 · 37 citations · 6 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsLigand-based DesignPotency OptimizationQuantitative Structure-activity RelationshipsReceptor ModelingReceptor PharmacologyStructure-activity Relationship AnalysisAssayChemokine Receptor PharmacologyMedicinal Chemistry ApplicationsMolecular Property-based DesignReceptor Binding OptimizationStructure - Activity Relationship OptimizationStructure - Pharmacokinetic Relationship AnalysisStructure-activity Relationship Modeling
The design, synthesis, and structure-activity relationship development of naphthalene-derived human CCR8 antagonists is described. In vitro binding assay results of these investigations are reported, critical interactions of the antagonists with CCR8 are defined, and preliminary physicochemical and pharmacokinetic data for the naphthalene scaffold are presented.
6
HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8
Daniel J. Dairaghi, Rong A. Fan, Brian E. McMaster et al. · Journal of Biological Chemistry · 1999 · 190 citations · Full text
Nasreen S. Haque, John T. Fallon, Mark B. Taubman et al. · Blood · 2001 · 89 citations · Full text